Hirotaka Iwase - Search Results

Year	Number of Results
2002	4
2003	9
2004	5
2005	5
2006	12
2007	8
2008	10
2009	15
2010	8
2011	9
2012	14
2013	13
2014	12
2015	17
2016	13
2017	15
2018	12
2019	7
2020	5
2021	2
2022	1
2023	1
2024	0

1

Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer.

André F, Ciruelos E, Rubovszky G, Campone M, Loibl S, Rugo HS, Iwata H, Conte P, Mayer IA, Kaufman B, Yamashita T, Lu YS, Inoue K, Takahashi M, Pápai Z, Longin AS, Mills D, Wilke C, Hirawat S, Juric D; SOLAR-1 Study Group. André F, et al. N Engl J Med. 2019 May 16;380(20):1929-1940. doi: 10.1056/NEJMoa1813904. N Engl J Med. 2019. PMID: 31091374 Clinical Trial.

2

Cancer Navigation Strategy for Endocrine Therapy-Resistant Breast Tumors.

Nakao M, Fujiwara S, Iwase H. Nakao M, et al. Among authors: iwase h. Trends Cancer. 2018 Jun;4(6):404-407. doi: 10.1016/j.trecan.2018.04.005. Epub 2018 May 19. Trends Cancer. 2018. PMID: 29860984 Review.

3

Lenvatinib: A Promising Molecular Targeted Agent for Multiple Cancers.

Suyama K, Iwase H. Suyama K, et al. Among authors: iwase h. Cancer Control. 2018 Jan-Dec;25(1):1073274818789361. doi: 10.1177/1073274818789361. Cancer Control. 2018. PMID: 30032643 Free PMC article. Review.

4

The role of exosomal microRNAs; focus on clinical applications in breast cancer.

Sueta A, Yamamoto Y, Iwase H. Sueta A, et al. Among authors: iwase h. Cancer Drug Resist. 2019 Sep 19;2(3):847-861. doi: 10.20517/cdr.2019.17. eCollection 2019. Cancer Drug Resist. 2019. PMID: 35582569 Free PMC article. Review.

5

Roles of long noncoding RNAs in chromosome domains.

Tomita S, Abdalla MO, Fujiwara S, Yamamoto T, Iwase H, Nakao M, Saitoh N. Tomita S, et al. Among authors: iwase h. Wiley Interdiscip Rev RNA. 2017 Mar;8(2). doi: 10.1002/wrna.1384. Epub 2016 Aug 3. Wiley Interdiscip Rev RNA. 2017. PMID: 27489248 Review.

6

Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor.

Iwase H. Iwase H. Int J Clin Oncol. 2015 Apr;20(2):249-52. doi: 10.1007/s10147-015-0795-6. Epub 2015 Feb 10. Int J Clin Oncol. 2015. PMID: 25666484 Review. No abstract available.

7

[Breast cancer].

Iwase H. Iwase H. Nihon Rinsho. 2006 Sep 28;Suppl 3:379-83. Nihon Rinsho. 2006. PMID: 17022569 Review. Japanese. No abstract available.

8

Clinical imaging for the prediction of neoadjuvant chemotherapy response in breast cancer.

Hayashi M, Yamamoto Y, Iwase H. Hayashi M, et al. Among authors: iwase h. Chin Clin Oncol. 2020 Jun;9(3):31. doi: 10.21037/cco-20-15. Chin Clin Oncol. 2020. PMID: 32594748 Free article. Review.

9

Development of a Machine Learning-Based Prognostic Model for Hormone Receptor-Positive Breast Cancer Using Nine-Gene Expression Signature.

Takeshita T, Iwase H, Wu R, Ziazadeh D, Yan L, Takabe K. Takeshita T, et al. Among authors: iwase h. World J Oncol. 2023 Oct;14(5):406-422. doi: 10.14740/wjon1700. Epub 2023 Sep 20. World J Oncol. 2023. PMID: 37869243 Free PMC article.

10

Clinical significance of estrogen receptor β in breast and prostate cancer from biological aspects.

Omoto Y, Iwase H. Omoto Y, et al. Among authors: iwase h. Cancer Sci. 2015 Apr;106(4):337-43. doi: 10.1111/cas.12613. Epub 2015 Mar 9. Cancer Sci. 2015. PMID: 25611678 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

166 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

166 results

Results by year